2014
DOI: 10.1016/j.radonc.2014.11.009
|View full text |Cite
|
Sign up to set email alerts
|

On the pre-clinical validation of a commercial model-based optimisation engine: Application to volumetric modulated arc therapy for patients with lung or prostate cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
185
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 168 publications
(189 citation statements)
references
References 17 publications
4
185
0
Order By: Relevance
“…These results echoed the superiority of knowledge‐based solution over the conventional trial‐and‐error manual planning, in line with previous publications 17, 20, 22, 23, 24, 25, 26, 27. It suggested that knowledge‐ and geometry‐based dosimetric predictions can help avoid selecting suboptimal or conflict optimization constraints as manual limitations.…”
Section: Discussionsupporting
confidence: 87%
See 1 more Smart Citation
“…These results echoed the superiority of knowledge‐based solution over the conventional trial‐and‐error manual planning, in line with previous publications 17, 20, 22, 23, 24, 25, 26, 27. It suggested that knowledge‐ and geometry‐based dosimetric predictions can help avoid selecting suboptimal or conflict optimization constraints as manual limitations.…”
Section: Discussionsupporting
confidence: 87%
“…Well‐trained RapidPlan models have outperformed conventional trial and error‐based manual planning by reducing excess organs‐at‐risk (OAR) dose with greater consistency 17, 20, 22, 23, 24, 25, 26, 27, 28, 29, 30. Should the model performance be highly dependent on the library volume31 and average quality of the training plans,17, 32 incorporating the model‐improved constituent training plans into the model (closed‐loop)25 may potentially evolve the model as a cycle of interactive improvement.…”
Section: Introductionmentioning
confidence: 99%
“…Twenty more plans (8 low/intermediate‐risk cases, 6 second phase cases, and 6 Post‐op cases) were added to improve the statistics for the regression of this structure. The decreased values for both coefficient of determination and chi‐squared test for the final model reflect the reduction in over‐fitting (chi‐squared test results closer to 1 correspond to better fits16). …”
Section: Resultsmentioning
confidence: 99%
“…Fogliata et al. have evaluated the performance of RapidPlan using volumetric arc therapy in hepatocellular, lung, and prostate cancer 16, 17. Their results showed that RapidPlan models can be used to achieve clinically acceptable plans.…”
Section: Introductionmentioning
confidence: 99%
“…Although the RapidPlan model generated identical optimization objectives for the same patient anatomy and beam geometry (except jaws), the knowledge‐based planning module in the proposed optimal jaw searching method is intended to avoid subjective planner dependence, and to personalize the automated optimization in case of different patient anatomy, prescription, field geometry and energies, which were all modeled by RapidPlan in dose prediction 9, 17, 18, 19, 20. However, it is highly desired that, the next versions of RapidPlan should model the actual jaw settings for more accurate dose estimation, which may potentially serve as a fast and sensitive indicator of dosimetric changes with various jaw settings.…”
Section: Discussionmentioning
confidence: 99%